Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.
Vicky Lee Ng, Barbara H Haber, John C Magee...
https://pubmed.ncbi.nlm.nih.gov/25015575/Actively Recruiting
Led by Arbor Research Collaborative for Health · Updated on 2026-06-04
1265
Participants Needed
16
Research Sites
N/A
Total Duration
Researchers are studying biliary atresia, a liver condition in infants and children, to better understand what causes it and how it progresses over time. This observational study aims to identify the genes involved in biliary atresia and to describe the natural history of older children who still have their native liver. The study is conducted by the Childhood Liver Disease Research Network funded by the National Institute of Diabetes & Digestive and Kidney Diseases. The study involves collecting clinical information, genetic material, and body fluid samples from participants once, usually at the start of the study. Participants include children and young adults aged over 6 months up to 20 years who have a confirmed diagnosis of biliary atresia and still have their native liver. Researchers will follow these participants yearly to gather observational data about disease progression and quality of life. Participants will be asked to attend yearly follow-up visits where observational information will be collected, including health status and growth measurements. The primary measurement is to identify genetic factors linked to biliary atresia, while secondary outcomes include understanding disease progression and quality of life over time. The study tracks important health events, growth, and nutritional status to help predict outcomes. Participation may last several years, with annual visits to monitor the condition and collect data.
CONDITIONS
Biliary Atresia Study in Infants and Children
M
Melissa Sexton, BBA, CCRP
M
Melissa Sexton, BBA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Arbor Research Collaborative for Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 7 years
Participants who have biliary atresia and their native liver are observed to collect clinical information, genetic material, and body fluid samples to study disease progression and related factors.
Annual visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Vicky Lee Ng, Barbara H Haber, John C Magee...
https://pubmed.ncbi.nlm.nih.gov/25015575/Arbor Research Collaborative for Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor